Eric Hedrick is Chief Medical Officer at Epizyme, Inc. (EPZM). They have made 1 open-market trade across 1 company since 2014, most recently 2021-12-17.
CIK 0001502677
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | SELL · 10b5-1 | 2014-10-15 | 2014-10-17 | $23.38 | $47K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-09-15 | 2014-09-15 | $28.67 | $57K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-08-15 | 2014-08-19 | $38.60 | $77K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-07-15 | 2014-07-17 | $31.35 | $63K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-06-16 | 2014-06-18 | $26.42 | $53K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL | 2014-02-10 | 2014-02-12 | $29.25 | $395K | -37.3% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.